Australia: 352238, 2013378673
Canada: 149729, 152322, 2870491
New Zealand: 417908, 710948
United States: 9289076, D742630, 9492019, 9339119, 9603466, 9808098, 10213030
South Africa: 2015/06757
Additional International Patents Pending.
[TORONTO, March 21, 2018] - S2S Innovations, Inc., maker of patented neonatal products including SleepBelt™ and Joeyband® by SleepBelt, successfully resolved a dispute over its patents in the District of Connecticut with Tarry Medical Products Inc., maker of DandleLION Medical products.
According to the settlement agreement, Tarry Medical (and any of its Affiliates) cannot make, use, or sell the KangaROO Kuddler 1 (“KK1”), KangaROO Kuddler 2 (“KK2”), or Revised KangaROO Kuddler 2 (“Revised KK2”) products, anywhere in the world, after a limited sell-off period. Tarry Medical was granted a 120 day sell-off period so it can honour terms of pre-existing agreements.
“We have invested in our intellectual property with the safety and benefits of our clients in mind. We are pleased that the strength of our patent portfolio quickly brought this matter to a close and S2S can continue to expand its reach in the marketplace,” said Ashley Wade, Co-Founder.
ABOUT S2S INNOVATIONS, INC.
S2S launched their skin-to-skin and infant fall prevention device in 2013, which is used in over one hundred hospitals in North America. SleepBelt™, the consumer product, and Joeyband®, the clinical product, are the exclusive skin-to-skin products of La Leche League International. Joeyband is a 2016 AWHONN (Association of Women’s Health, Obstetrics, and Neonatal Nurses) “Trusted Leader,” and the premier product designed to support skin-to-skin and prevent infant falls across the continuum of care – in the Operating Room, Labor/Delivery, Neonatal Intensive Care Unit, and at Home.
CONTACT and GENERAL INQUIRIES:
Vice President, Business Development
Joeyband is not for co-sleeping, and is not a carrier.